NexImmune Inc. (NEXI) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    NexImmune Inc.

    OTC: NEXI · Real-Time Price · USD
    0.00
    -0.00 (-100.00%)
    At close: Apr 04, 2025, 11:37 AM

    NexImmune Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 3.2M 34.64M 30.33M
    Short-Term Investments
    		 1.44M n/a 51.49M
    Long-Term Investments
    		 n/a n/a n/a
    Other Long-Term Assets
    		 1.79M 264.97K 324.1K
    Receivables
    		 n/a 74.47K n/a
    Inventory
    		 n/a -19.47K n/a
    Other Current Assets
    		 235.25K 456.92K 99.19K
    Total Current Assets
    		 5.4M 37.37M 86.28M
    Property-Plant & Equipment
    		 1.4M 5.43M 4.43M
    Goodwill & Intangibles
    		 n/a n/a n/a
    Total Long-Term Assets
    		 3.19M 5.69M 4.75M
    Total Assets
    		 8.59M 43.06M 91.03M
    Account Payables
    		 1.34M 2.38M 1.05M
    Deferred Revenue
    		 n/a n/a n/a
    Short-Term Debt
    		 n/a n/a n/a
    Other Current Liabilities
    		 n/a n/a n/a
    Total Current Liabilities
    		 5.08M 10.33M 7.22M
    Long-Term Debt
    		 n/a n/a n/a
    Other Long-Term Liabilities
    		 n/a n/a 55.58K
    Total Long-Term Liabilities
    		 n/a 425.77K 55.58K
    Total Liabilities
    		 5.08M 10.76M 7.27M
    Total Debt
    		 68.81K 1.02M n/a
    Common Stock
    		 2.65K 2.61K 2.28K
    Retained Earnings
    		 -222.59M -190.25M -127.74M
    Comprehensive Income
    		 n/a n/a 3.01K
    Shareholders Equity
    		 3.51M 32.3M 83.76M
    Total Investments
    		 1.44M n/a 51.49M

    Add to Watchlist